Search clinical trials for: STA-5326 mesylate
Total 3277 results
-
Synta Pharmaceuticals Corp.CompletedCrohn's DiseaseUnited States, Canada
-
Synta Pharmaceuticals Corp.National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedCrohn's DiseaseUnited States
-
Synta Pharmaceuticals Corp.CompletedActive, Moderate to Severe Rheumatoid ArthritisNetherlands
-
Synta Pharmaceuticals Corp.Completed
-
National Institute of Allergy and Infectious Diseases...CompletedCrohn's DiseaseUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedCommon Variable ImmunodeficiencyUnited States
-
Baylor College of MedicineCompletedObsessive-Compulsive Disorder | Anxiety Disorders | Generalized Anxiety Disorder | Autism Spectrum Disorder | Social Anxiety Disorder | Specific Phobia | Cognitive Behavioral TherapyUnited States
-
Eisai LimitedCompleted
-
University of ZurichCompletedHigh Altitude Pulmonary HypertensionSwitzerland
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
Weill Medical College of Cornell UniversityCompleted
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Radiation Therapy Oncology Group; American...CompletedGastrointestinal Stromal TumorUnited States
-
Emory UniversitySynta Pharmaceuticals Corp.TerminatedStage IVA Oral Cavity Squamous Cell Carcinoma | Stage IVA Laryngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage I Hypopharyngeal Squamous Cell Carcinoma | Stage I Laryngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
Sarepta Therapeutics, Inc.TerminatedCardiovascular Disease | Coronary Artery BypassUkraine
-
Sinphar Pharmaceutical Co., LtdCompletedVascular DementiaChina
-
Shenzhen TargetRx, Inc.The First Affiliated Hospital of Soochow UniversityNot yet recruitingNon Small Cell Lung Cancer
-
Kynexis B.V.ParexelRecruitingSchizophrenia | Cognitive DysfunctionUnited States
-
Mansoura UniversityRecruitingLocal Anesthesia | Pain PerceptionEgypt
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Myrexis Inc.CompletedHIV-1 InfectionUnited States
-
Shandong Suncadia Medicine Co., Ltd.Not yet recruitingLipoprotein Disorder Disease
-
Chengdu Zenitar Biomedical Technology Co., LtdNot yet recruitingAdvanced Solid TumorChina
-
Le Syndicat Intercommunal pour le Thermalisme et...University Grenoble Alps; FloralisRecruitingChronic Venous InsufficiencyFrance
-
University of Alabama at BirminghamActive, not recruitingGingival Recession | Lack of Keratinized GingivaUnited States
-
University of Alabama at BirminghamActive, not recruitingGingival RecessionUnited States
-
Memorial Sloan Kettering Cancer CenterSynta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.CompletedSolid TumorsUnited States
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
AEterna ZentarisM.D. Anderson Cancer CenterCompletedGastrointestinal Stromal Tumors
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompleted
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance